The report provides a detailed analysis essential for establishing an Atomoxetine Hydrochloride production plant. It encompasses all critical aspects necessary for Atomoxetine Hydrochloride production, including the cost of Atomoxetine Hydrochloride production, Atomoxetine Hydrochloride plant cost, Atomoxetine Hydrochloride production costs, and the overall Atomoxetine Hydrochloride production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Atomoxetine Hydrochloride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Atomoxetine Hydrochloride is mainly used in the pharmaceutical industry as the active ingredient in medications for treating Attention-Deficit/Hyperactivity Disorder (ADHD). It is a selective norepinephrine reuptake inhibitor that improves focus, attention, and behavioural control. The compound is formulated into pharmaceutical compositions combined with suitable carriers for therapeutic use in ADHD and related neurological disorders.
The market for Atomoxetine Hydrochloride is primarily driven by the rising global cases of Attention-Deficit/Hyperactivity Disorder (ADHD) and increasing awareness and diagnosis rates. Atomoxetine’s positioning as a non-stimulant alternative to traditional ADHD treatments attracts patients and caregivers concerned about stimulant-associated side effects and abuse potential, broadening its patient base.
Advances in healthcare infrastructure, improved mental health services accessibility, and ongoing pharmaceutical R&D for enhanced formulations further support market growth. However, advanced synthesis technology that ensures high purity (>98%) and efficient production is critical to meeting regulatory standards and market demand, which impacts industrial atomoxetine hydrochloride procurement. Additionally, growing emphasis on eco-friendly production practices influences supplier evaluation and long-term procurement planning.
Raw Material for Atomoxetine Hydrochloride Production
According to the Atomoxetine Hydrochloride production plant project report, the raw material for Atomoxetine Hydrochloride production includes 3-chloropropiophenone.
Production Process of Atomoxetine Hydrochloride
The extensive Atomoxetine Hydrochloride production cost report consists of the following major industrial production process:
- Production via nucleophilic substitution reaction: The production process of Atomoxetine Hydrochloride involves the introduction of the 3-aryloxy substituent using nucleophilic aromatic substitution due to the high cost and difficulty of large-scale Mitsunobu reactions. It starts with the asymmetric reduction of 3-chloropropiophenone using borane and (S)-oxazaborolidine catalyst in THF at 0 degree Celsius, yielding a chiral alcohol, which is further purified. This chiral alcohol is treated with dimethylamine in ethanol to form a dimethylamine alcohol intermediate. In the next step, nucleophilic aromatic substitution is performed with sodium hydride in DMSO and a fluorobenzene derivative to produce an imine intermediate. Hydrolysis of the imine gives an aldehyde, which is reduced to an alcohol, then converted to a chloride using thionyl chloride, followed by zinc reduction under acidic conditions, yielding a methyl adduct. The final steps involve the transformation of the dimethylamine group to monomethylamine using phenyl chloroformate and triethylamine, followed by the formation of the hydrochloride salt under reflux in ethyl acetate, producing Atomoxetine Hydrochloride.
Properties of Atomoxetine Hydrochloride
Atomoxetine Hydrochloride is a white to almost white crystalline solid with a molecular formula of C17H22ClNO and a molecular weight of 291.82 g/mol. It has a melting point in the range of 167 to 171 degree Celsius and exhibits high purity greater than 98% by HPLC analysis. It is soluble in methanol and also moderately soluble in water (27.8 mg/mL). The compound has a pKa of 10.13, indicating basicity primarily due to the amine functional group. Its specific rotation is about -42° (C=1, MeOH), reflecting its chiral nature.
Atomoxetine Hydrochloride is heat-sensitive and stored under refrigerated or frozen conditions to maintain stability. It acts as a selective norepinephrine reuptake inhibitor with limited activity at other neurotransmitter systems, contributing to its pharmacological profile as a non-stimulant treatment for ADHD. The molecule consists of aromatic rings and a secondary amine with stereochemical specificity, crucial for its biological activity.